Message from the Chair and Executive Director Lukas and Liliana announce winners of the IAHPC Members’ Recognition awards, and offer their perspective on both World Hospice and Palliative Care Day and how palliative care intersects with COVID-19. Policy and Advocacy Dr. Katherine
Chronic spinal pain is disabling and has high personal and societal costs. Risk factors include behavioural factors; however, little is known about the role of diet quality and its association with spinal pain. Higher diet quality and consumption of macronutrients
Palliative care for persons with Parkinson’s disease: a qualitative study on the experiences of health care professionals
Parkinson’s disease (PD) is a chronic and neurodegenerative disease associated with a wide variety of symptoms. The risk of complications increases with progression of the disease. These complications have a tremendous impact on the quality of life of people with
October 2020 PEM OCTOBER 2020 President’s Message I am honored and privileged to assume the role of President of the International Association for the Study of Pain (IASP). IASP has been an important part of my life for a long
Sorry, but only PainSA members can view this content click here to login.
Chronic pain is a widespread problem in the field of pediatrics. Many interventions to ameliorate pain-related dysfunction have a biobehavioral focus. As treatments for chronic pain (e.g., increased movement) often stand in stark contrast to treatments for an acute injury
Inconsistent associations between modifiable risk factors and chronic back pain (CBP) may be due to the inability of traditional epidemiologic study designs to properly account for an array of potential genetic and environmental confounding factors. The co-twin control research design,
Attitudes of registered nurses about the end – of – life care in multi-profile hospitals: a cross sectional survey
End-of-life care is provided in a variety of healthcare settings, not just palliative care hospitals. This is one reason why it is very important to assess all barriers to end-of-life care and to provide safe and quality services to patients.
Clonidine was first synthesized in Germany in 1962 and introduced into clinical practice in 1966 as an antihypertensive drug. In children, the indications for its use have increased to cover a wide range of conditions such as attention deficit hyperactivity
The Global Alliance for Musculoskeletal Health (G-MUSC) invites the PainSA and its members to participate in an important global consultation on musculoskeletal healthcare. G-MUSC supports the global musculoskeletal health community, including consumers, healthcare providers, civil society and healthcare organisations, governments and